UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.00 0.00 (0.00%) GOLD FUTURES
2,311.30 +0.30 (+0.01%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
46,913.51 +1,102.99 (+2.41%)
Astellas Pharma Inc. (ALPMF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:37PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 17.33B |
| Enterprise value | 21.05B |
| Trailing P/E | 561.66 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.74 |
| Price/book (mrq) | 1.78 |
| Enterprise value/revenue | 0.01 |
| Enterprise value/EBITDA | 0.13 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.29 |
| 52-week change 3 | -37.33% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 17.00 |
| 52-week low 3 | 9.13 |
| 50-day moving average 3 | 10.60 |
| 200-day moving average 3 | 12.46 |
Share statistics
| Avg vol (3-month) 3 | 2.44k |
| Avg vol (10-day) 3 | 7.28k |
| Shares outstanding 5 | 1.79B |
| Implied shares outstanding 6 | 1.82B |
| Float 8 | 1.79B |
| % held by insiders 1 | 0.25% |
| % held by institutions 1 | 50.98% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.48 |
| Forward annual dividend yield 4 | 5.01% |
| Trailing annual dividend rate 3 | 70.00 |
| Trailing annual dividend yield 3 | 735.22% |
| 5-year average dividend yield 4 | 2.59 |
| Payout ratio 4 | 2,452.83% |
| Dividend date 3 | 18 Jun 2018 |
| Ex-dividend date 4 | 30 Sept 2024 |
| Last split factor 2 | 5:1 |
| Last split date 3 | 27 Mar 2014 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 1.06% |
| Operating margin (ttm) | -7.98% |
Management effectiveness
| Return on assets (ttm) | 1.80% |
| Return on equity (ttm) | 1.10% |
Income statement
| Revenue (ttm) | 1.6T |
| Revenue per share (ttm) | 894.27 |
| Quarterly revenue growth (yoy) | 17.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 244.7B |
| Net income avi to common (ttm) | 17.05B |
| Diluted EPS (ttm) | 0.02 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 335.69B |
| Total cash per share (mrq) | 187.23 |
| Total debt (mrq) | 920.02B |
| Total debt/equity (mrq) | 57.65% |
| Current ratio (mrq) | 0.93 |
| Book value per share (mrq) | 890.18 |
Cash flow statement
| Operating cash flow (ttm) | 172.48B |
| Levered free cash flow (ttm) | 109.61B |
© 2024 Yahoo. All rights reserved.